Details for Patent: 9,623,014
Which drugs does patent 9,623,014 protect, and when does it expire?
Patent 9,623,014 protects XACDURO (COPACKAGED) and is included in one NDA.
This patent has forty-four patent family members in thirty-nine countries.
Summary for Patent: 9,623,014
| Title: | β-lactamase inhibitor compounds |
| Abstract: | The present invention is directed to compounds which are beta-lacatamase inhibitors. The compounds and their pharmaceutically acceptable salts, are useful in combination with beta-lactam antibiotics, or alone, for the treatment of bacterial infections, including infections caused by drug resistant organisms, including multi-drug resistant organisms. The present invention includes compounds according to formula (Ia): or a pharmaceutically acceptable salt thereof, wherein the values of R1, R2, R3 and R4 are described herein. |
| Inventor(s): | Helen McGuire, Shanta Bist, Neil Bifulco, Liang Zhao, Ye Wu, Hoan Huynh, Hui Xiong, Janelle Comita-Prevoir, Daemian Dussault, Bolin Geng, Brendan Chen, Thomas Francois Durand-Reville, Satenig Guler |
| Assignee: | AstraZeneca UK Ltd , Entasis Therapeutics Ltd , AstraZeneca Pharmaceuticals LP |
| Application Number: | US15/056,090 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,623,014 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,623,014
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Entasis Therap | XACDURO (COPACKAGED) | durlobactam sodium; durlobactam sodium; sulbactam sodium | POWDER;INTRAVENOUS | 216974-001 | May 23, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | TREATMENT OF HOSPITAL-ACQUIRED BACTERIAL PNEUMONIA AND VENTILATOR-ASSOCIATED BACTERIAL PNEUMONIA (HABP/VABP) | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,623,014
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 090539 | ⤷ Start Trial | |||
| Australia | 2013245399 | ⤷ Start Trial | |||
| Brazil | 112014024279 | ⤷ Start Trial | |||
| Canada | 2866467 | ⤷ Start Trial | |||
| Chile | 2014002589 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
